Latest News

Free To Choose Medicine in Japan: A Model for America

In Defense of Free to Choose Medicine

Trump’s FDA Pick Should Let Patients Be Free to Choose, By Bartley Madden and Susan Dudley

Allowing Patients to Choose Could Save Billions

President Trump’s FDA Nominee Could Mean Better Drugs Sooner at Lower Cost

Free To Choose Medicine and Right To Try

The Pathway to Faster Cures

An early version of FTCM was distributed in a Japanese booklet and played a role in Japan’s passage of legislation in 2013 that implemented FTCM principles for regenerative medicine drugs. A Forbes op-ed (December 1, 2015) with the economist Vernon Smith, “Give the FDA Some Competition with Free To Choose Medicine,” click here, highlights the benefits from FTCM and the importance of Japan’s market-based approach. For more information on this topic, click here.